Andreas Mentis

TL;DR: Medline, PubMed and the Cochrane databases were searched on epidemiology and diagnosis of Helicobacter pylori for the period of April 2011–March 2012, and none of these techniques, at present, are specific enough for obtaining a real‐time diagnosis of H.pylori infection.

TL;DR: A dysregulated interferon response whereby IFN-λ and type I IFN production were diminished and delayed in patients with COVID-19, exhibiting a response that is ‘untuned’ with other inflammatory cytokines is reported.

TL;DR: Results show that administration of TMEWP may be effective in reducing H. pylori colonization and that the major triterpenic acids in the acid extract may be responsible for such an activity.

TL;DR: Altered cytokine patterns in COVID-19 patients correlate with longer hospitalization time and higher incidence of critical disease and mortality compared to flu, pointing to an untuned antiviral response in CO VID-19 contributing to persistent viral presence, hyperinflammation and respiratory failure.

TL;DR: In eastern Europe, primary H. pylori resistance to metronidazole is considerable, and that to clarithromycin is similar to or slightly higher than that in western Europe.